Journal
BIOPHARMACEUTICS & DRUG DISPOSITION
Volume 29, Issue 8, Pages 441-448Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/bdd.629
Keywords
ABCB11; BSEP; bile salt transport; cholestasis; species difference
Categories
Ask authors/readers for more resources
The dog bile salt export pump (BSEP; ABCB11) was cloned and expressed in a Sf9 insect cell system. The deduced amino acid sequence encodes a 1325-amino-acid protein, which shows 89.4% and 80.2% homology with human BSEP and rat Bsep, respectively. The transcript of the dog Bsep gene was detected at a high level in liver, but not other tissues, by quantitative RTPCR. The BSEP-expressing membrane vesicles isolated from Sf9 cells exhibited saturable uptake of [(3)H]taurocholic acid with Michaelis constants (K(m)) of 33.7, 22.2 and 19.9 mu M for the dog, rat and human transporters, respectively. The uptake of [(3)H]taurocholic acid by all three transporters was significantly inhibited by troglitazone, glibenclamide, and other several inhibitors, while pravastatin inhibited dog Bsep and human BSEP, but not rat Bsep at 100 mu M. The IC(50) Of troglitazone for dog Bsep, human BSEP, and rat Bsep were 32, 20, and 60 mu M, and those of pravastatin were 441, 240 and > 1,000 mu M, respectively. In conclusion, while dog Bsep shows similar ATP-dependent bile acid transport characteristics to human BSEP and rat Bsep, there is a species difference in affinity for drugs such as pravastatin and troglitazone. Copyright (C) 2008 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available